Vanda Pharmaceuticals Inc... (VNDA)
NASDAQ: VNDA
· Real-Time Price · USD
4.37
-0.06 (-1.35%)
At close: Aug 15, 2025, 3:59 PM
4.33
-0.92%
After-hours: Aug 15, 2025, 04:23 PM EDT
Vanda Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 80.98M | 111.8M | 102.32M | 100.5M | 102.95M | 125.16M | 135.82M | 183.19M | 150.03M | 354.17M | 135.03M | 49.4M | 58.23M | 66.93M | 52.07M | 50.52M | 57.24M | 72.13M |
Short-Term Investments | 244.57M | 229.11M | 272.33M | 275.76M | 284.72M | 268.98M | 252.44M | 306.67M | 339.32M | 147.32M | 331.83M | 405.39M | 382.63M | 368.25M | 380.74M | 355.45M | 339.25M | 306.03M |
Long-Term Investments | 469K | n/a | n/a | n/a | 469K | 469K | 469K | 469K | 469K | 469K | 469K | 469K | n/a | 518K | 519K | 519K | 523K | 522K |
Other Long-Term Assets | 9.15M | 10.06M | 9.1M | 9.32M | 8.89M | 9.05M | 9.52M | 9.81M | 9.48M | 9.99M | 10.91M | 9.88M | 8.85M | 8.41M | 7.63M | 7.99M | 7.48M | 5.87M |
Receivables | 44.99M | 44.6M | 47.1M | 42.75M | 41.86M | 36.71M | 34.16M | 29.27M | 33.62M | 24.51M | 33.51M | 29.35M | 28.8M | 30.5M | 32.47M | 41.5M | 37.09M | 31.47M |
Inventory | 2.17M | 1.92M | 1.73M | 1.61M | 1.47M | 1.5M | 1.36M | 1.01M | 1.08M | 1.1M | 1.19M | 1.59M | 1.5M | 1.29M | 1.02M | 902K | 1.05M | 1.36M |
Other Current Assets | 22.21M | 20.48M | 15.42M | 11.76M | 8.17M | 7.07M | 9.17M | 16.44M | 9.45M | 6.59M | 17.73M | 21.37M | 25.74M | 25.3M | 12M | 13.44M | n/a | n/a |
Total Current Assets | 394.92M | 407.91M | 438.89M | 432.39M | 439.18M | 439.43M | 432.95M | 536.57M | 533.5M | 533.71M | 519.29M | 507.11M | 496.89M | 492.27M | 478.3M | 461.81M | 446.65M | 421.22M |
Property-Plant & Equipment | 12.47M | 12.47M | 12.68M | 8.19M | 8.68M | 9.05M | 9.14M | 9.56M | 9.95M | 10.43M | 10.97M | 10.86M | 11.35M | 11.86M | 12.38M | 12.9M | 13.53M | 14.03M |
Goodwill & Intangibles | 110.59M | 112.34M | 114.1M | 115.85M | 117.6M | 119.35M | 121.37M | 17.43M | 17.81M | 18.19M | 18.57M | 18.94M | 19.32M | 19.7M | 20.08M | 20.45M | 20.82M | 21.19M |
Total Long-Term Assets | 229.82M | 224.03M | 217.31M | 212.73M | 212.19M | 213.26M | 215.49M | 105.03M | 108.18M | 110.83M | 114.95M | 114.68M | 112.21M | 111.29M | 115.49M | 117.96M | 120.99M | 121.97M |
Total Assets | 624.75M | 631.94M | 656.2M | 645.12M | 651.37M | 652.68M | 648.44M | 641.61M | 641.68M | 644.53M | 634.25M | 621.79M | 609.1M | 603.56M | 593.79M | 579.77M | 567.64M | 543.19M |
Account Payables | 4M | 5.99M | 3.5M | 5.81M | 2.27M | 4.34M | 7.14M | 3.49M | 2.17M | 3.8M | 12.69M | 13.43M | 16.41M | 14.33M | 925K | 1.3M | 2.12M | 5.32M |
Deferred Revenue | n/a | n/a | n/a | n/a | 54.19M | n/a | n/a | -5.86M | -4.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.12M |
Short-Term Debt | 4.68M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 105.91M | 62.44M | 69.36M | 56.47M | 83.04M | 81.97M | 71.74M | 71.61M | 75.81M | 81.09M | 64.6M | 65.64M | 59.48M | 65.89M | 58.8M | 56.91M | 57.8M | 48.42M |
Total Current Liabilities | 121.49M | 103.92M | 99.98M | 89.09M | 93.79M | 93.34M | 87.7M | 84.84M | 87.4M | 93.79M | 91.44M | 92.62M | 88.4M | 90.74M | 74.42M | 72M | 71.99M | 61.78M |
Long-Term Debt | 6.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 9.97M | 9.24M | 9.59M | 9.32M | 9.06M | 8.83M | 8.83M | 6.2M | 6.45M | 6.61M | 6.8M | 4.61M | 2.87M | 1.03M | 4.39M | 3.99M | 3.7M | 2.65M |
Total Long-Term Liabilities | 16.93M | 16.6M | 17.68M | 14.8M | 15.06M | 15.35M | 15.83M | 13.67M | 14.39M | 15M | 15.61M | 13.51M | 12.15M | 10.69M | 14.45M | 14.45M | 14.44M | 13.78M |
Total Liabilities | 138.42M | 120.52M | 117.66M | 103.89M | 108.86M | 108.69M | 103.53M | 98.5M | 101.78M | 108.79M | 107.05M | 106.13M | 100.55M | 101.44M | 88.86M | 86.45M | 86.42M | 75.56M |
Total Debt | 11.64M | 11.74M | 12.36M | 7.94M | 8.43M | 8.92M | 9.4M | 7.47M | 7.94M | 10.73M | 11.14M | 11.1M | 11.53M | 11.96M | 10.05M | 12.75M | 10.74M | 11.13M |
Common Stock | 59K | 59K | 58K | 58K | 58K | 58K | 58K | 58K | 57K | 57K | 57K | 57K | 57K | 56K | 56K | 56K | 56K | 56K |
Retained Earnings | -230.99M | -203.79M | -174.29M | -169.38M | -164.06M | -159.54M | -155.39M | -152.99M | -153.13M | -154.65M | -157.9M | -164.76M | -168.03M | -170.61M | -164.18M | -171.25M | -179.03M | -188.68M |
Comprehensive Income | 396K | 383K | 74K | 702K | -330K | -383K | -30K | -967K | -865K | -255K | -1.19M | -1.49M | -1.43M | -1.33M | -175K | 111K | 103K | 192K |
Shareholders Equity | 486.33M | 511.42M | 538.55M | 541.22M | 542.52M | 544M | 544.91M | 543.1M | 539.9M | 535.74M | 527.2M | 515.66M | 508.55M | 502.12M | 504.93M | 493.32M | 481.22M | 467.63M |
Total Investments | 245.04M | 229.11M | 272.33M | 275.76M | 284.72M | 268.98M | 252.44M | 306.67M | 339.32M | 147.32M | 331.83M | 405.39M | 382.63M | 368.25M | 380.74M | 355.45M | 339.25M | 306.03M |